The Neuropathy Recovery Program

Peripheral Neuropathy Treatment Diet

Get Instant Access

1. Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev 1999; 7:245-252.

2. Tesfaye S, Stephens L, Stephenson J, et al. The prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39:1377-1384.

3. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-154.

4. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38:1456-1461.

5. Ziegler D. Diagnosis, staging and epidemiology of diabetic peripheral neuropathy. Diab Nutr Metab 1994;7:342-348.

6. Tesfaye S, Chaturvedi N, Eaton SEM, Witte D, Ward JD, Fuller J. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-350.

7. Boulton AJM, Kirsner RS, Viliekyte L. Neuropathic diabetic foot ulcers. N Engl J Med 2004;351:48-55.

8. Tesfaye S. Diabetic neuropathy: achieving best practice. Br J Vasc Dis 2003;3:112-117.

9. Watkins PJ, Edmonds ME. Clinical features of diabetic neuropathy, in Textbook of Diabetes (Pickup J, Williams G, eds.), 1997, Vol. 2, pp. 50.1-50.20.

10. Ward JD. Clinical features of diabetic neuropathy. in Diabetic Neuropathy (Ward JD, Goto Y, eds.), Chichester, UK., Wiley, 1990, pp. 281-296.

11. Bruyn GW, Garland H. Neuropathies of endocrine origin. in Handbook of clinical neurology (Vinken PJ, Bruyn GW, eds.), Amsterdam, North-Holland Publishing Co., 1970, Vol. 8, 29p.

12. Thomas PK. Metabolic neuropathy. J Roy Coll Phys (Lond) 1973;7:154-160.

13. Low PA, Suarez GA. Diabetic neuropathies. in Bailliere's Clinical Neurology 1995;4(3):401-425.

14. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic Somatic neuropathies. Diabetes Care 2004;27:1458-1486.

15. Eaton SEM, Tesfaye S. Clinical manifestations and measurement of somatic neuropathy. Diabetes Rev 1999;7:312-325.

16. Scott LA, Tesfaye S. Measurement of somatic neuropathy for clinical practice and clinical trials. Curr Diabetes Rep 2001;1:208-215.

17. Andersen H, Jakobsen J. Motor function in diabetes. Diabetes Rev 1999;7:326-341.

18. Watkins PJ. Pain and diabetic neuropathy. Br Med J 1984;288:168-169.

19. Tesfaye S, Price D. Therapeutic approaches in diabetic neuropathy and neuropathic pain. in Diabetic Neuropathy. (Boulton AJM, ed.), 1997;159-181.

20. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996;348:1696-1701.

21. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003;(Suppl 1):S1-S8.

22. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF. Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 1981;21:18-24.

23. Ward JD. The diabetic leg. Diabetologia 1982;22:141-147.

24. Rajbhandari SM, Jenkins R, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002;1085-1096.

25. Ward JD, Simms JM, Knight G, Boulton AJM, Sandler DA. Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J Roy Soc Med 1983;76:1011-1014.

26. Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arterial venous shunting? Diabetologia 1982;22:6-8.

27. Edmonds ME, Archer AG, Watkins PJ. Ephedrine: a new treatment for diabetic neuropathic oedema. Lancet 1983;1(8324):548-551.

28. Said G, Slama G, Selva J. Progressive centripital degeneration of of axons in small-fibre type diabetic polyneuropathy. A clinical and pathological study. Brain 1983;106:791.

29. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000;43:957-973.

30. Veves A, Young MJ, Manes C, et al. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a Clinical study. Diabetes Care 1994;17:1200-1202.

31. Ward JD, Tesfaye S. Pathogenesis of diabetic neuropathy. in Textbook of Diabetes (Pickup J, Williams G, eds.), 1997, Vol. 2, pp. 49.1- 49.19.

32. Cameron NE, Eaton SE, Cotter MA, Tesfaye S.Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001;44:1973-1988.

33. Tesfaye S, Harris N, Jakubowski J, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993;36:1266-1274.

34. Eaton SE, Harris ND, Ibrahim S, et al. Differnces insural nerve haemodynamics in painful and painless neuropathy. Diabetologia 2003;934-939.

35. Malik RA, Tesfaye S, Newrick PG, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005;48:578-585.

36. Boulton AJM, Armstrong WD, Scarpello JHB, Ward JD. The natural history of painful diabetic neuropathy - a 4 year study. Postgrad Med J 1983;59:556-559.

Benbow SJ, Chan AW, Bowsher D, McFarlane IA, Williams G. A prospective study of painful symptoms, small fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabetic Med 1994;11:17-21.

Chan AW, MacFarlane IA, Bowsher DR, Wells JC, Bessex C, Griffiths K. Chronic pain in patients with diabetes mellitus: comparison with non-diabetic population. Pain Clin 3 1990;147-159.

Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 1986;35:192-197.

Tsigos C, White A, Young RJ. Discrimination between painful and painless diabetic neuropathy based on testing of large somatic nerve and sympathetic nerve function. Diabetic Med 1992;9:359-365.

Veves A, Manes C, Murray HJ, Young MJ, Boulton AJM. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993;16:1187-1189. Young MJ, Manes C, Boulton AJM. Vibration perception threshold predicts foot ulceration: a prospective study (Abstract). Diabetic Med 1992;9(Suppl 2):542. Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia 2005;48:805-807. Archer AG, Watkins PJ, Thomas PJ, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neorosurg Psychiatr 1983;46:491-496. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974;23:418-423. Guy RJC, Clark CA, Malcolm PN, Watkins PJ. Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia, 1985;28:131. Caravati CM. Insulin neuritis: a case report. Va MedMon 1933;59:745-746. Tesfaye S, Malik R, Harris N, et al. Arteriovenous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996;39:329-335.

Llewelyn JG, Thomas PK, Fonseca V, King RHM, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (Berl) 1986;72: 157-163.

Tesfaye S, Harris N, Wilson RM, Ward JD. Exercise induced conduction veolcity increment: a marker of impaired nerve blood flow in diabetic neuropathy. Diabetologia 1992;35:155-159.

Kihara M, Zollman PJ, Smithson IL, et al. Hypoxic effect of endogenous insulin on normal and diabetic peripheral nerve. Am J Physiol 1994;266:E980-E985. Matikainen E, Juntunen J. Diabetic neuropathy: Epidemiological, pathogenetic, and clinical aspects with special emphasis on type 2 diabetes mellitus. Acta Endocrinol Suppl (Copenh) 1984;262:89-94.

Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus:

a clinicopathological study. Brain 1970;93:555-557.

Garland H. Diabetic amyotrophy. Br Med J 1955;2:1287-1290.

Coppack SW, Watkins PJ. The natural history of femoral neuropathy. Q J Med 1991; 79:307-313.

Casey EB, Harrison MJG. Diabetic amyotrophy: a follow-up study. Br Med J 1972;1:656. Garland H, Taverner D. Diabetic myelopathy. Br Med J 1953;1:1405. Subramony SH, Willbourn AJ. Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci 1982;53:293-304.

Bastron JA, Thomas JE. Diabetic polyradiculoneuropathy: clinical and electromyographic findings in 105 patients. Mayo Clinic Proc 1981;56:725-732.

Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994;33:559-569. Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve 2003;27:465-470.

62. Steward JD, McKelvey R, Durcan L, Carpenter S, Karpati G. Chronic inflammatory demyelinating polyneuropathy (CIPD) in diabetes. J Neurol Sci 1996;142:59-64.

63. Koller H, Kieseier BC, Jander S, Hartung H. Chronic Inflammatory Demyelinating Polyneuropathy. NEJM 2005;352:1343-1356.

64. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from an ad hoc sub-committee of the America Academy of Neurology AIDS Task Force. Neurology 1991;41:617-618.

65. Wilson JR, Park Y, Fisher MA. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy. Electromyogr Clin Neurophsiol 2000;40:181-185.

66. Molenaar DS, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64: 84-89.

67. Gabriel CM, Howard R, Kinsella N, et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 2000;69:442-446.

68. Vital C, Vital A, Lagueny A, et al. Chronic inflammatory demyelinating polyneuropathy; immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases. Ultrastruct Pathol 2000;24:363-369.

69. Cocito D, Ciaramitaro P, Isoardo G, et al. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP. J Neurol 2002;249:719-722.

70. Sharma KR, Cross J, Ayyar DR, Martinez-Arizala A, Bradley WG. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy. Arch Neurol 2002; 59:751-757.

71. Zorilla E, Kozak GP. Ophthalmoplegia in diabetes mellitus. Ann Internal Med 1967;67:968-976.

72. Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 1960;64:592-600.

73. Leslie RDG, Ellis C. Clinical course following diabetic ocular palsy. Postgrad Med J 1978;54:791-792.

74. Dreyfuss PM, Hakim S, Adams RD. Diabetic ophthalmoplegia. Arch Neurol Psychiatry 1957;77:337-349.

75. Ellenberg M. Diabetic truncal mononeuropathy—a new clincal syndrome. Diabetes Care 1978;1:10-13.

76. Boulton AJM, Angus E, Ayyar DR, Weiss R. Diabetic thoracic polyradiculopathy presenting as abdominal swelling. BMJ 1984;289:798-799.

77. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-824.

78. Clayburgh RH, Beckenbaugh RD, Dobyns JH. Carp[el tunnel release in patients with diffuse peripheral neuropathy. J Hand Surg 1987;12A:380-383.

79. White JES, Bullock RF, Hudgson P, Home PD, Gibson GJ. Phrenic neuropathy in association with diabetes. Diabet Med 1992;9:954-956.

Was this article helpful?

0 0
Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment